Princeton, NJ, United States of America

Mohammad R Seyedsayamdost

This inventor holds 12 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Princeton University, Harvard College, Scripps Research Institute. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammad R Seyedsayamdost. Retrieved from https://idiyas.com/inventor/mohammad-r-seyedsayamdost

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 75.0

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Newton, MA (US) (2012 - 2015)
  • Princeton, NJ (US) (2018 - 2023)

Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Mohammad R Seyedsayamdost**

Introduction

Mohammad R Seyedsayamdost, an esteemed inventor based in Princeton, NJ, holds a total of five patents that significantly contribute to the field of bacterial pathogen research and antibiotic discovery. His groundbreaking work focuses on utilizing existing drugs in novel ways to combat virulence in bacteria, showcasing the potential of innovation in addressing public health challenges.

Latest Patents

One of Seyedsayamdost's latest patents is centered around the use of guanfacine as an anti-virulence agent. This patent discloses methods for employing guanfacine, alongside its analogs and derivatives, to effectively reduce the virulence of bacterial pathogens. The treatment method involves administering a therapeutically effective dose of guanfacine to patients or applying it directly to the bacterial pathogens.

Another notable patent details the discovery of cryptic metabolites and outlines methods for activating silent biosynthetic gene clusters in actinomycete bacteria. This invention introduces a high-throughput transcriptional assay format that employs enhanced green fluorescent protein (eGFP) as an indicator for secondary metabolite synthesis. By using this innovative approach, Seyedsayamdost was able to induce a silent gene cluster, revealing potent cytotoxins that can lead to the identification of novel antifungal compounds and inhibitors for cancer-related cysteine proteases.

Career Highlights

Seyedsayamdost is currently affiliated with Princeton University, where he conducts his research and continues to innovate within the domain of microbiology and pharmaceutical sciences. His work contributes to the development of new methodologies that enhance drug effectiveness in combating resistant bacterial strains, which is a significant concern in modern medicine.

Collaborations

During his career, Seyedsayamdost has collaborated with various researchers, including Fei Xu and Yihan Wu. These partnerships not only enhance the scope of his research but also foster an environment of shared knowledge and innovation within the scientific community.

Conclusion

Mohammad R Seyedsayamdost stands as a prominent figure in the field of microbiological research, with his patents reflecting the intersection of creativity and scientific rigor. His contributions are crucial for advancing our understanding of bacterial pathogens and improving therapeutic strategies, ultimately benefiting public health and showcasing the impact of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…